all of promus element everolimus-eluting coronary stent system
מדיסון פארמה בע"מ - רופא - coronary heart disease
"coronary stent helistent, titan 2."
"הקסקט יש.בע""מ" - מומחה - לטיפול בחולים עם הצרות של העורקים הכליליים במצבים חריפים וכרוניים.
coronary stent helistent, titan 2.
הקסקט יש.בע"מ - מומחה - לטיפול בחולים עם הצרות של העורקים הכליליים במצבים חריפים וכרוניים.
coronary and peripheral guides wires and access.
לבנט טכנולוגיות בע"מ - מומחה
coronary stent + delivery system
גאמידה בע"מ - מומחה - היצרות בעורקים הקורונריים
coronary stent carbostent"- sirius"
לפידות מדיקל יבוא ושיווק בע"מ - רופא - תמיכה בקוטר קטטר קורונרי בשעת ההחדרה לעורק
coronary dilatation and guiding catheter .
לבנט טכנולוגיות בע"מ - מומחה
mguard prime
inspire md ltd - רופא - mguard prime coronary stent system is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in the following cases: • symptomatic coronary artery disease due to discrete de novo or restenotic lesion in native coronary artery. • symptomatic coronary artery disease due to culprit lesion in saphenous vein graft • treatment of coronary lesion in patients undergoing primary or rescue pci for acute st-segment elevation myocardial infarction(stemi) • treatment of coronary lesion having atherothrombotic appearance in patients with non st-elevation acute coronary syndromes (unstable angina and non st-segment elevation myocardial infarction).
קלופידוגרל טבע
teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or